USE OF RGM AND ITS MODULATORS

Details for Australian Patent Application No. 2002231736 (hide)

Owner MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V.

Inventors MANN, Matthias; ANDERSEN, Jens, S.; MUELLER, Bernhard, K.; MONNIER, Philippe, P.; MACCHI, Paolo; BONHOEFFER, Friedrich; STAHL, Bernd MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. BERLIN see EVOTEC OAI AG (21) 2002238479

Pub. Number AU-A-2002231736

PCT Pub. Number WO2002/051438

Priority 00128356.3 22.12.00 EP

Filing date 21 December 2001

Wipo publication date 8 July 2002

International Classifications

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61K 038/17 Medicinal preparations containing peptides - from animals

A61K 031/7088 - Compounds having three or more nucleosides or nucleotides

A61P 009/00 Drugs for disorders of the cardiovascular system

A61P 025/00 Drugs for disorders of the nervous system

A61P 035/00 Antineoplastic agents

A61P 037/00 Drugs for immunological or allergic disorders

Event Publications

23 January 2003 Application Open to Public Inspection

  Published as AU-A-2002231736

5 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002231737-METHOD COMPUTER SYSTEM AND COMPUTER PROGRAM PRODUCT FOR UPDATING A WEB PAGE

2002231735-TRANSFECTION COMPLEXES (TRANSOPLEX) HAVING A REDUCED TOXICITY, A HIGHER PHYSICAL STABILITY, AND A HIGHER TRANSFECTION EFFICIENCY, AND A METHOD FOR THE PRODUCTION THEREOF